ELAPRASE
TAK-665-4003
Approved small_molecule terminated
Quick answer
ELAPRASE for Mucopolysaccharidosis (MPS) is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Mucopolysaccharidosis (MPS)
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated